非小细胞肺癌患者中循环肿瘤细胞的预测作用

王汉萍 已出版文章查询
王汉萍
本平台内已出版文章查询
1 张力 已出版文章查询
张力
本平台内已出版文章查询
1

+ 作者地址

1中国医学科学院北京协和医院呼吸内科,北京,100730


0
  • 摘要
  • 参考文献
  • 相关文章
  • 统计
恶性肿瘤患者的血液中可检测到循环肿瘤细胞circulating tumor cells,CTC。转移性乳腺癌、结直肠癌和前列腺癌中外周血CTC与疾病的复发及治疗反应的临床相关性已经被确立。研究晚期肺癌患者中CTC与临床的相关性对指导临床治疗的非常重要。CTC可能成为临床上提示肺癌预后预测疾病进展指导治疗的重要因素,将CTC检测转化到临床实践中并进一步改善标准化的CTC检测技术有重要意义。

[1] Fehm T;Sagalowsky A;Clifford E et al.Cytogenetic ev-idence that circulating epithelial cells in patients with carcinoma are malignant[J].Clinical Cancer Research,2002,8(07):2073-2084.

[2] Alama A;Truini A;Coco S et al.Prognostic and predic-tive relevance of circulating tumor cells in patients with non-small-cell lung cancer[J].DRUG DISCOVERY TODAY,2014,19(10):1671-1676.

[3] Thomson S;Petti F;Sujka Kwok I;Mercado P;Bean J;Monaghan M;Seymour SL;Argast GM;Epstein DM;Haley JD .A systems view of epithelial-mesenchymal transition signaling states.[J].Clinical and experimental metastasis,2011(2):137-155.

[4] Pain M;Bermudez O;Lacoste P et al.Tissue remodel-ling in chronic bronchial diseases:from the epithelial to mesenchymal phenotype[J].Eur Respir Rev,2014,23(131):118-130.

[5] Molecular mechanisms of epithelial-mesenchymal transition[J].Nature reviews: molecular cell biology,2014(3):178-196.

[6] Cristofanilli M;Budd GT;Ellis MJ;Stopeck A;Matera J;Miller MC;Reuben JM;Doyle GV;Allard WJ;Terstappen LW;Hayes DF .Circulating tumor cells, disease progression, and survival in metastatic breast cancer.[J].The New England journal of medicine,2004(8):781-791.

[7] Cristofanilli M;Hayes DF;Budd GT;Ellis MJ;Stopeck A;Reuben JM;Doyle GV;Matera J;Allard WJ;Miller MC;Fritsche HA;Hortobagyi GN;Terstappen LW .Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.[J].Journal of Clinical Oncology,2005(7):1420-1430.

[8] Cohen SJ;Alpaugh RK;Gross S et al.Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer[J].Clin Colorectal Can-cer,2006,6(02):125-132.

[9] Okegawa T;Nutahara K;Higashihara E .Prognostic sig-nificance of circulating tumor cells in patients with hor-mone refractory prostate cancer[J].Journal Of Urology,2009,181(03):1091-1097.

[10] Hou JM;Krebs M;Ward T;Sloane R;Priest L;Hughes A;Clack G;Ranson M;Blackhall F;Dive C .Circulating tumor cells as a window on metastasis biology in lung cancer.[J].American Journal of Pathology: Official Publication of the American Association of Pathologists,2011(3):989-996.

[11] O'Flaherty,J.D.;Gray,S.;Richard,D.;Fennell,D.;O'Leary,J.J.;Blackhall,F.H.;O'Byrne,K.J. .Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer[J].Lung cancer: Journal of the International Association for the Study of Lung Cancer,2012(1):19-25.

[12] Siegel,R.;Naishadham,D.;Jemal,A. .Cancer statistics, 2013[J].CA: A cancer journal for clinicians,2013(1):11-30.

[13] Grossi F;Kubota K;Cappuzzo F;de Marinis F;Gridelli C;Aita M;Douillard JY .Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens.[J].The oncologist,2010(10):1102-1112.

[14] Genova C;Rijavec E;Truini A et al.Pemetrexed for the treatment of non-small cell lung cancer[J].EXPERT OPINION ON PHARMACOTHERAPY,2013,14(11):1545-1558.

[15] Aita M;Fasola G;Defferrari C .Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer.[J].Critical reviews in oncology/hematology,2008(3):183-196.

[16] Rosell,R.;Carcereny,E.;Gervais,R.;Vergnenegre,A.;Massuti,B.;Felip,E.;Palmero,R.;Garcia-Gomez,R.;Pallares,C.;Sanchez,J.M.;Porta,R.;Cobo,M.;Garrido,P.;Longo,F.;Moran,T.;Insa,A.;DeMarinis,F.;Corre,R.;Bover,I.;Illiano,A.;Dansin,E.;deCastro,J.;Milella,M.;Reguart,N.;Altavilla,G.;Jimenez,U.;Provencio,M.;Moreno,M.A.;Terrasa,J.;Mu?oz-Langa,J.;Valdivia,J.;Isla,D.;Domine,M.;Molinier,O.;Mazieres,J.;Baize,N.;Garcia-Campelo,R.;Robinet,G.;Rodriguez-Abreu,D.;Lopez-Vivanco,G.;Gebbia,V.;Ferrera-Delgado,L.;Bombaron,P.;Bernabe,R.;Bearz,A.;Artal,A.;Cortesi,E.;Rolfo,C.;Sanchez-Ronco,M.;Drozdowskyj,A.;Queralt,C.;deAguirre,I.;Ramirez,J.L.;Sanchez,J.J.;Molina,M.A.;Taron,M.;Paz-Ares,L. .Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial[J].The lancet oncology,2012(3):239-246.

[17] Favoni,R.E.;Alama,A. .Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout[J].Drug discovery today,2013(1/2):11-24.

[18] Alice T. Shaw;Dong-Wan Kim .Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer[J].The New England journal of medicine,2013(25):2385-2394.

[19] Katz RL;He W;Khanna A et al.Genetically abnormal circulating cells in lung cancer patients:an antigen-in-dependent fluorescence in situ hybridization-based case-control study[J].Clinical Cancer Research,2010,16(15):3976-3987.

[20] Campos,M.;Luque,R.;Jiménez,J.;Martínez,R.;Warleta,F.;Sánchez-Quesada,C.;Delgado-Rodríguez,M.;Calvo,A.;Gaforio,J.J. .Simultaneous phenotypic and genetic characterization of single circulating tumor cells from colon cancer patients[J].Histology and histopathology,2013(10/12):1439-1450.

[21] Harouaka,R.;Kang,Z.;Zheng,S.-Y.;Cao,L. .Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications[J].Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics,2014(2):209-221.

[22] Mostert B;Kraan J;Bolt de Vries J;van der Spoel P;Sieuwerts AM;Schutte M;Timmermans AM;Foekens R;Martens JW;Gratama JW;Foekens JA;Sleijfer S .Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.[J].Breast cancer research and treatment,2011(1):33-41.

[23] Oka,S.;Uramoto,H.;Chikaishi,Y.;Tanaka,F. .The expression of CD146 predicts a poor overall survival in patients with adenocarcinoma of the lung[J].Anticancer Research: International Journal of Cancer Research and Treatment,2012(3):861-864.

[24] Imbert AM;Garulli C;Choquet E et al.CD146 expres-sion in human breast cancer cell lines induces pheno-typic and functional changes observed in epithelial to mesenchymal transition[J].PLoS One,2012,7(08):e43752.

[25] Botteri E;Sandri MT;Bagnardi V;Munzone E;Zorzino L;Rotmensz N;Casadio C;Cassatella MC;Esposito A;Curigliano G;Salvatici M;Verri E;Adamoli L;Goldhirsch A;Nole F .Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.[J].Breast cancer research and treatment,2010(1):211-217.

[26] Garrigos N;Gallego J;Guillen Ponce C;Guaraz P;Garcia Bautista M;Castillejo A;Gomez Martinez A;Carrato A;Rodriguez Lescure A;Soto JL .Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study.[J].Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,2010(2):142-147.

[27] Cohen SJ;Punt CJ;Iannotti N;Saidman BH;Sabbath KD;Gabrail NY;Picus J;Morse M;Mitchell E;Miller MC;Doyle GV;Tissing H;Terstappen LW;Meropol NJ .Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.[J].Journal of Clinical Oncology,2008(19):3213-3221.

[28] de-Bono JS;Scher HI;Montgomery RB;Parker C;Miller MC;Tissing H;Doyle GV;Terstappen LW;Pienta KJ;Raghavan D .Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.[J].Clinical cancer research: an official journal of the American Association for Cancer Research,2008(19):6302-6309.

[29] Farace F;Massard C;Vimond N;Drusch F;Jacques N;Billiot F;Laplanche A;Chauchereau A;Lacroix L;Planchard D;Le Moulec S;Andre F;Fizazi K;Soria JC;Vielh P .A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas.[J].The British journal of cancer,2011(6):847-853.

[30] Krebs MG;Hou JM;Sloane R;Lancashire L;Priest L;Nonaka D;Ward TH;Backen A;Clack G;Hughes A;Ranson M;Blackhall FH;Dive C .Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.[J].Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer,2012(2):306-315.

[31] Chinen LT;de Carvalho FM;Rocha BM et al.Cytoker-atin-based CTC counting unrelated to clinical follow up[J].J Thorac Dis,2013,5(05):593-599.

[32] Yu Y;Chen Z;Dong J et al.Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer[J].Transl Oncol,2013,6(06):697-702.

[33] Sawabata N;Okumura M;Utsumi T;Inoue M;Shiono H;Minami M;Nishida T;Sawa Y .Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method.[J].General thoracic and cardiovascular surgery,2007(5):189-192.

[34] Tanaka F;Yoneda K;Kondo N .Circulating tumor cell as a diagnostic marker in primary lung cancer.[J].Clinical cancer research: an official journal of the American Association for Cancer Research,2009(22):6980-6986.

[35] V Hofman;E Long;M Ilie;C Bonnetaud;J M Vignaud;J F Fléjou;S Lantuejoul;E Piaton;N Mourad;C Butori;E Selva;C H Marquette;M Poudenx;S Sibon;S Kelhef;N Vénissac;J P Jais;J Mouroux;T J Molina;P Vielh;P Hofman .Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method.[J].Cytopathology,2012(1):30-38.

[36] Hofman V;Bonnetaud C;Ilie MI;Vielh P;Vignaud JM;Flejou JF;Lantuejoul S;Piaton E;Mourad N;Butori C;Selva E;Poudenx M;Sibon S;Kelhef S;Venissac N;Jais JP;Mouroux J;Molina TJ;Hofman P .Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.[J].Clinical cancer research: an official journal of the American Association for Cancer Research,2011(4):827-835.

[37] Hofman V;Ilie MI;Long E;Selva E;Bonnetaud C;Molina T;Venissac N;Mouroux J;Vielh P;Hofman P .Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method.[J].International Journal of Cancer =: Journal International du Cancer,2011(7):1651-1660.

[38] Krebs MG;Sloane R;Priest L;Lancashire L;Hou JM;Greystoke A;Ward TH;Ferraldeschi R;Hughes A;Clack G;Ranson M;Dive C;Blackhall FH .Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.[J].Journal of Clinical Oncology,2011(12):1556-1563.

[39] Ma XL;Xiao ZL;Liu L et al.Meta-analysis of circu-lating tumor cells as a prognostic marker in lung cancer[J].Asian Pacific Journal of Cancer Prev,2012,13(04):1137-1144.

[40] Wang J;Wang K;Xu J et al.Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients:a meta-analysis[J].PLoS One,2013,8(11):e78070.

[41] Maheswaran S;Sequist LV;Nagrath S;Ulkus L;Brannigan B;Collura CV;Inserra E;Diederichs S;Iafrate AJ;Bell DW;Digumarthy S;Muzikansky A;Irimia D;Settleman J;Tompkins RG;Lynch TJ;Toner M;Haber DA .Detection of mutations in EGFR in circulating lung-cancer cells.[J].The New England journal of medicine,2008(4):366-377.

[42] Punnoose EA;Atwal SK;Spoerke JM et al.Molecular biomarker analyses using circulating tumor cells[J].PLoS One,2010,5(09):e12517.

[43] Punnoose,E.A.;Atwal,S.;Liu,W.;Raja,R.;Fine,B.M.;Hughes,B.G.M.;Hicks,R.J.;Hampton,G.M.;Amler,L.C.;Pirzkall,A.;Lackner,M.R. .Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib[J].Clinical cancer research: an official journal of the American Association for Cancer Research,2012(8):2391-2401.

[44] Ran, R.;Li, L.;Wang, M.;Wang, S.;Zheng, Z.;Lin, P.P. .Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood[J].Analytical and bioanalytical chemistry,2013(23):7377-7382.

[45] Emma Pailler;Julien Adam;Amélie Barthélémy;Marianne Oulhen;Nathalie Auger;Alexander Valent;Isabelle Borget;David Planchard;Melissa Taylor;Fabrice André;Jean Charles Soria;Philippe Vielh;Benjamin Besse;Fran?oise Farace .Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer.[J].Journal of Clinical Oncology,2013(18):2273-2281.

[46] Heitzer,E.;Auer,M.;Gasch,C.;Pichler,M.;Ulz,P.;Hoffmann,E.M.;Lax,S.;Waldispuehl-Geigl,J.;Mauermann,O.;Lackner,C.;H?fler,G.;Eisner,F.;Sill,H.;Samonigg,H.;Pantel,K.;Riethdorf,S.;Bauernhofer,T.;Geigl,J.B.;Speicher,M.R. .Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing[J].Cancer research: The official organ of the American Association for Cancer Research, Inc,2013(10):2965-2975.

[47] Daniels M;Goh F;Wright CM et al.Whole genome sequencing for lung cancer[J].J Thorac Dis,2012,4(02):155-163.

[48] Hirose,T.;Murata,Y.;Oki,Y.;Sugiyama,T.;Kusumoto,S.;Ishida,H.;Shirai,T.;Nakashima,M.;Yamaoka,T.;Okuda,K.;Ohnishi,T.;Ohmori,T. .Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer[J].Oncology Research,2012(2/3):131-137.

[49] Juan O;Vidal J;Gisbert R et al.Prognostic signifi-cance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine[J].Clin Transl Oncol,2014,16(07):637-643.

[50] Muinelo-Romay L;Vieito M;Abalo A et al.Evalua-tion of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in ad-vanced NSCLC patients receiving first-line systemic treatment[J].Cancers(Basel),2014,6(01):153-165.



期刊热词
  • + 更多
  • 字体大小